VOR Vor Biopharma Inc. - Common Stock
$24,23
Kurs · Aug 19, 2026
Fundamentaldaten per Aug 11, 2026
52W-Spanne
$6–$50
41% of range
Analystenbewertung
BUY
13 analysts
Kursziel
$39
+61% upside
P/E (TTM)
-0.5
ROE
83.4%
Nettogewinnmarge
—
VOR Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$24.23
Marktkapitalisierung
$1.31B
P/E (TTM)
-0.5
EPS (TTM)
$-70.50
Umsatz (TTM)
—
Dividendenrendite
0.00%
ROE
83.4%
Verschuldungsgrad
—
52W-Spanne
$7 – $50
VOR Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Configure
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz & Nettoergebnis
—
EPS
$-70.50
2021-12-31
→
2025-12-31
Freier Cashflow
$-144M
2021-12-31
→
2025-12-31
Margen
—
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
Kennzahl
5-Jahres-Trend
VOR
Peer-Median
P/E (TTM)
-0.5
—
P/B (K/B)
-8.0
5.2
Price / FCF (Kurs / FCF)
-9.1
—
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
Kennzahl
5-Jahres-Trend
VOR
Peer-Median
ROA
-229.3%
-44.7%
ROE
83.4%
-51.5%
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
Kennzahl
5-Jahres-Trend
VOR
Peer-Median
Current Ratio (Liquiditätsgrad)
18.2
9.5
Quick Ratio
18.1
—
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
Kennzahl
5-Jahres-Trend
VOR
Peer-Median
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
Kennzahl
5-Jahres-Trend
VOR
Peer-Median
Payout Ratio (Ausschüttungsquote)
0.00%
—
Dividenden Rendite, Ausschüttungsquote, Dividendenhistorie, 5-Jahres-CAGR
Dividendenrendite
0.00%
Ausschüttungsquote
0.00%
5J Div CAGR
—
VOR Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
KAUF
13 Analysten
- Starker Kauf 5 38,5%
- Kauf 6 46,2%
- Halten 2 15,4%
- Verkauf 0 0,0%
- Starker Verkauf 0 0,0%
12-Monats-Kursziel
8 Analysten · 2026-08-17
Median
$40.00
← Unter allen Zielen
$24.23
Tief
$27.00
Hoch
$50.00
Median-Ziel
$40.00
+65,1%
Mittelwert-Ziel
$39.00
+61,0%
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
-2.6%
| Zeitraum | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|
| 31. März 2026 | $-5.11 | $-0.79 | -4.3% |
| 31. Dezember 2025 | $25.84 | $-1.69 | 27.5% |
| 30. September 2025 | $-3.33 | $-3.28 | -0.05% |
| 30. Juni 2025 | $-43.80 | $-8.86 | -34.9% |
| 31. März 2025 | $-5.20 | $-4.62 | -0.58% |
| 31. Dezember 2024 | $-8.80 | $-5.77 | -3.0% |
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| VOR | $506M | -0.2 | — | — | 83.4% | — |
| CRVS | $575M | -14.5 | — | — | -21.6% | — |
| MNKD | $1.75B | 283.5 | 22.2% | 1.7% | -11.1% | — |
| REPL | $633M | -2.3 | — | — | -146.2% | — |
| SANA | $1.09B | -4.2 | — | — | -172.3% | — |
| SVRA | $1.23B | -11.4 | — | — | -73.4% | — |
| AVTX | $336M | -3.1 | -86.6% | -132642.4% | -83.4% | — |
| ARDX | $1.42B | -22.4 | 22.1% | -15.1% | -40.2% | — |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung 12
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| R&D Expense | $322M | $93M | $94M | $65M | $48M | $32M | |
| SG&A Expense | $50M | $28M | $32M | $29M | $21M | $12M | |
| Operating Expenses | $372M | $121M | $126M | $93M | $69M | $43M | |
| Operating Income | $-372M | $-121M | $-126M | $-93M | $-69M | $-43M | |
| Interest Income | $6M | $4M | $8M | $1M | $119.0K | $29.0K | |
| Other Non-op | $-324M | $4M | $8M | $1M | $119.0K | $29.0K | |
| Net Income | $-696M | $-117M | $-118M | $-92M | $-69M | $-43M | |
| EPS (Basic) | $-70.50 | $-34.03 | $-1.75 | $-2.33 | $-2.10 | · | |
| EPS (Diluted) | $-70.50 | $-34.03 | $-1.75 | $-2.33 | $-2.10 | · | |
| Shares (Basic) | 9,871,866 | 3,435,533 | 67,191,973 | 39,551,420 | 33,433,214 | · | |
| Shares (Diluted) | 9,871,866 | 3,435,533 | 67,191,973 | 39,551,420 | 33,433,214 | · | |
| EBITDA | $-372M | $-121M | $-126M | $-93M | $-69M | · |
Bilanz 21
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $396M | $82M | $31M | $58M | $120M | $49M | |
| Short-term Investments | $59M | $10M | $106M | $173M | $88M | $0 | |
| Prepaid Expense | $1M | $4M | $3M | $4M | $5M | $467.0K | |
| Other Current Assets | $2M | $380.0K | $475.0K | $2M | $2M | $100.0K | |
| Current Assets | $458M | $97M | $141M | $237M | $214M | $49M | |
| PP&E (Net) | $533.0K | $7M | $10M | $13M | $7M | $5M | |
| PP&E (Gross) | $558.0K | $18M | $18M | $17M | $9M | $5M | |
| Accum. Depreciation | $25.0K | $11M | $8M | $5M | $2M | $726.0K | |
| Other Non-current Assets | $2M | $2M | $5M | $3M | $3M | $3M | |
| Total Assets | $464M | $143M | $198M | $299M | $243M | $76M | |
| Accounts Payable | $5M | $2M | $815.0K | $2M | $2M | $2M | |
| Accrued Liabilities | $20M | $13M | $11M | $8M | $6M | $6M | |
| Current Liabilities | $25M | $19M | $16M | $13M | $10M | $10M | |
| Capital Leases | $3M | $28M | $32M | $36M | $16M | $17M | |
| Total Liabilities | $628M | $46M | $47M | $49M | $26M | $28M | |
| Common Stock | $18.0K | $13.0K | $7.0K | $7.0K | $4.0K | $1.0K | |
| Retained Earnings | $-1.15B | $-457M | $-340M | $-222M | $-130M | $-61M | |
| AOCI | $41.0K | $22.0K | $-77.0K | $-770.0K | · | · | |
| Stockholders' Equity | $-164M | $97M | $151M | $251M | $216M | $-59M | |
| Liabilities + Equity | $464M | $143M | $198M | $299M | $243M | $76M | |
| Shares Outstanding | 38,720,196 | 6,238,799 | 3,395,072 | 65,996,138 | 37,174,741 | 505,074 |
Cashflow 11
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Stock-based Comp | $19M | $10M | $13M | $11M | $4M | $1M | |
| Restructuring | $30M | · | · | · | · | · | |
| Operating Cash Flow | $-143M | $-100M | $-100M | $-85M | $-69M | $-36M | |
| CapEx | $941.0K | $229.0K | $1M | $8M | $4M | $4M | |
| Investing Cash Flow | $-49M | $97M | $71M | $-94M | $-92M | $-4M | |
| Stock Issued | $70M | $275.0K | $5M | $4M | · | · | |
| Net Stock Activity | $70M | $275.0K | $5M | $4M | · | · | |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 | $0 | |
| Financing Cash Flow | $504M | $53M | $3M | $117M | $233M | $83M | |
| Net Change in Cash | $312M | $51M | $-26M | $-62M | $72M | $42M | |
| Free Cash Flow | $-144M | $-100M | $-101M | $-94M | $-73M | · |
Rentabilität 2
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| ROA | -229.3% | -68.6% | -47.4% | -34.0% | -43.3% | · | |
| ROE | 83.4% | -137.8% | -72.4% | -45.0% | -30.7% | · |
Liquidität & Solvenz 2
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Current Ratio | 18.2 | 5.2 | 9.0 | 18.1 | 21.1 | · | |
| Quick Ratio | 18.1 | 4.9 | 8.8 | 17.6 | 20.4 | · |
Bewertung (TTM) 11
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Net Income TTM | $-696M | $-117M | $-118M | $-92M | $-69M | $-43M | |
| Market Cap | $506M | $2.77B | $3.06B | $8.78B | $8.64B | · | |
| P/E | -0.2 | -0.7 | -25.7 | -57.1 | -110.7 | · | |
| P/B | -3.1 | 28.7 | 20.3 | 35.0 | 39.9 | · | |
| P / Tangible Book | · | 28.7 | 20.3 | 35.0 | 39.9 | · | |
| P / Cash Flow | -3.5 | -27.8 | -30.5 | -103.1 | -124.9 | · | |
| P / FCF | -3.5 | -27.7 | -30.1 | -93.8 | -118.3 | · | |
| Dividend Yield | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | · | |
| Earnings Yield | -539.0% | -153.3% | -3.9% | -1.8% | -0.90% | · | |
| Payout Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | · | |
| Annual Payout | $0 | $0 | $0 | $0 | $0 | $0 |
Gewinn- und Verlustrechnung 12
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $26M | $18M | $19M | $14M | $261M | $27M | $25M | $22M | $22M | $24M | $21M | $28M | $24M | $22M | $17M | $17M | |
| SG&A Expense | $22M | $18M | $17M | $14M | $13M | $7M | $6M | $7M | $7M | $8M | $7M | $8M | $8M | $9M | $8M | $7M | |
| Operating Expenses | $48M | $35M | $36M | $28M | $274M | $33M | $31M | $29M | $29M | $32M | $28M | $35M | $32M | $30M | $25M | $24M | |
| Operating Income | $-48M | $-35M | $-36M | $-28M | $-274M | $-33M | $-31M | $-29M | $-29M | $-32M | $-28M | $-35M | $-32M | $-30M | $-25M | $-24M | |
| Interest Income | $4M | $4M | $3M | $2M | $537.0K | $805.0K | $599.0K | $954.0K | $1M | $2M | $2M | $2M | $2M | $2M | $815.0K | $313.0K | |
| Other Non-op | $-15M | $-184M | $1.76B | $-785M | $-1.30B | $805.0K | $599.0K | $954.0K | $1M | $2M | $2M | $2M | $2M | $2M | $815.0K | $313.0K | |
| Net Income | $-63M | $-220M | $1.72B | $-813M | $-1.57B | $-32M | $-31M | $-28M | $-28M | $-31M | $-26M | $-33M | $-30M | $-28M | $-24M | $-24M | |
| EPS (Basic) | $-1.16 | $-5.11 | $63.95 | $-121.63 | $-251.24 | $-5.21 | $-25.12 | $-8.05 | $-0.41 | $-0.45 | $-0.38 | $-0.49 | $-0.45 | $-0.43 | $-0.51 | $-0.63 | |
| EPS (Diluted) | $-1.16 | $-5.11 | $63.95 | $-121.63 | $-251.24 | $-5.21 | $-25.12 | $-8.05 | $-0.41 | $-0.45 | $-0.38 | $-0.49 | $-0.45 | $-0.43 | $-0.51 | $-0.63 | |
| Shares (Basic) | 54,304,456 | 43,011,544 | -246,905,522 | 6,681,794 | 6,263,572 | 6,241,207 | -136,318,102 | 3,423,499 | 68,299,170 | 68,030,966 | -133,714,593 | 67,607,713 | 67,033,150 | 66,265,703 | -73,188,103 | 38,009,022 | |
| Shares (Diluted) | 54,304,456 | 43,011,544 | -246,905,522 | 6,681,794 | 6,263,572 | 6,241,207 | -136,318,102 | 3,423,499 | 68,299,170 | 68,030,966 | -133,714,593 | 67,607,713 | 67,033,150 | 66,265,703 | -73,188,103 | 38,009,022 | |
| EBITDA | $-48M | $-35M | · | $-28M | $-274M | $-33M | · | $-29M | $-29M | · | · | $-35M | $-32M | $-30M | · | $-24M |
Bilanz 21
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $108M | $170M | $396M | $160M | $191M | $50M | $82M | $53M | $76M | $45M | $31M | $45M | $32M | $42M | $58M | $61M | |
| Short-term Investments | $358M | $322M | $59M | $10M | $10M | $10M | $10M | $10M | $10M | $63M | $106M | $115M | $155M | $168M | $173M | $75M | |
| Prepaid Expense | $6M | $6M | $1M | $747.0K | $2M | $5M | $4M | $4M | $4M | $4M | $3M | $4M | $4M | $6M | $4M | $5M | |
| Other Current Assets | $3M | $3M | $2M | $1M | $449.0K | $297.0K | $380.0K | $285.0K | $272.0K | $507.0K | $475.0K | $667.0K | $539.0K | $459.0K | $2M | $2M | |
| Current Assets | $475M | $501M | $458M | $172M | $205M | $65M | $97M | $67M | $90M | $112M | $141M | $164M | $191M | $217M | $237M | $143M | |
| PP&E (Net) | $648.0K | $565.0K | $533.0K | $271.0K | $0 | $6M | $7M | $7M | $8M | $9M | $10M | $11M | $11M | $12M | $13M | $13M | |
| PP&E (Gross) | $738.0K | $618.0K | $558.0K | $272.0K | $0 | $18M | $18M | $18M | $18M | $18M | $18M | $18M | $18M | $17M | $17M | $17M | |
| Accum. Depreciation | $90.0K | $53.0K | $25.0K | $1.0K | $0 | $12M | $11M | $11M | $10M | $9M | $8M | $7M | $6M | $5M | $5M | $4M | |
| Other Non-current Assets | $2M | $2M | $2M | $269.0K | $420.0K | $2M | $2M | $3M | $3M | $5M | $5M | $4M | $3M | $3M | $3M | $3M | |
| Total Assets | $481M | $507M | $464M | $176M | $205M | $109M | $143M | $116M | $142M | $167M | $198M | $223M | $251M | $278M | $299M | $206M | |
| Accounts Payable | $4M | $1M | $5M | $885.0K | $669.0K | $4M | $2M | $1M | $2M | $2M | $815.0K | $1M | $2M | $3M | $2M | $824.0K | |
| Accrued Liabilities | $20M | $15M | $20M | $18M | $58M | $9M | $13M | $9M | $8M | $7M | $11M | $10M | $7M | $5M | $8M | $6M | |
| Current Liabilities | $25M | $16M | $25M | $19M | $59M | $17M | $19M | $14M | $14M | $13M | $16M | $15M | $13M | $13M | $13M | $11M | |
| Capital Leases | $3M | $3M | $3M | $3M | $0 | $27M | $28M | $29M | $30M | $31M | $32M | $33M | $34M | $35M | $36M | $37M | |
| Total Liabilities | $681M | $657M | $628M | $2.40B | $1.71B | $43M | $46M | $43M | $44M | $44M | $47M | $48M | $47M | $47M | $49M | $48M | |
| Common Stock | $19.0K | $19.0K | $18.0K | $15.0K | $13.0K | $13.0K | $13.0K | $7.0K | $7.0K | $7.0K | $7.0K | $7.0K | $7.0K | $7.0K | $7.0K | $4.0K | |
| Retained Earnings | $-1.44B | $-1.37B | $-1.15B | $-2.88B | $-2.06B | $-489M | $-457M | $-426M | $-399M | $-371M | $-340M | $-314M | $-281M | $-251M | $-222M | $-198M | |
| AOCI | $-922.0K | $-706.0K | $41.0K | $12.0K | $14.0K | $23.0K | $22.0K | $68.0K | $-70.0K | $-87.0K | $-77.0K | $-280.0K | $-436.0K | $-174.0K | $-770.0K | $-1M | |
| Stockholders' Equity | $-200M | $-150M | $-164M | $-2.23B | $-1.51B | $66M | $97M | $73M | $98M | $123M | $151M | $175M | $204M | $230M | $251M | $159M | |
| Liabilities + Equity | $481M | $507M | $464M | $176M | $205M | $109M | $143M | $116M | $142M | $167M | $198M | $223M | $251M | $278M | $299M | $206M | |
| Shares Outstanding | 54,455,751 | 54,185,582 | 38,720,196 | 9,026,922 | 125,645,952 | 124,851,547 | 6,238,799 | 68,663,065 | 68,357,884 | 68,215,771 | 67,891,311 | 67,785,469 | 67,433,560 | 66,934,897 | 65,996,138 | 38,393,211 |
Cashflow 10
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $9M | $9M | $7M | $8M | $2M | $2M | $2M | $2M | $3M | $3M | $2M | $3M | $4M | $4M | $4M | $3M | |
| Restructuring | · | · | $0 | $-1M | · | · | · | · | · | · | · | · | · | · | · | · | |
| Operating Cash Flow | $-25M | $-38M | $-23M | $-54M | $-35M | $-31M | $-24M | $-23M | $-22M | $-30M | $-24M | $-28M | $-24M | $-24M | $-18M | $-19M | |
| CapEx | $120.0K | $48.0K | $314.0K | $244.0K | $152.0K | $231.0K | $72.0K | $34.0K | $9.0K | $114.0K | $111.0K | $465.0K | $399.0K | $94.0K | $321.0K | $298.0K | |
| Investing Cash Flow | $-37M | $-263M | $-49M | $-244.0K | $646.0K | $-230.0K | $-72.0K | $-34.0K | $53M | $44M | $10M | $41M | $14M | $6M | $-97M | $13M | |
| Stock Issued | · | · | $50M | $20M | $0 | $0 | $-22.0K | $111.0K | $-92.0K | $278.0K | $-15.0K | $392.0K | $579.0K | $4M | $106.0K | $4M | |
| Net Stock Activity | · | · | · | · | · | $0 | · | · | · | · | · | · | · | $4M | · | · | |
| Financing Cash Flow | $-106.0K | $75M | $308M | $22M | $175M | $-606.0K | $53M | $41.0K | $-31.0K | $96.0K | $25.0K | $176.0K | $218.0K | $3M | $112M | $4M | |
| Net Change in Cash | $-62M | $-227M | $236M | $-32M | $141M | $-32M | $29M | $-23M | $31M | $14M | $-14M | $13M | $-10M | $-15M | $-3M | $-2M | |
| Free Cash Flow | · | $-38M | · | · | · | $-31M | · | · | · | · | · | · | · | $-24M | · | · |
Rentabilität 2
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -18.3% | -71.3% | · | -556.2% | -907.1% | -23.5% | · | -16.3% | -14.2% | · | · | -15.5% | -12.6% | -11.1% | · | -10.2% | |
| ROE | 7.4% | 520.6% | · | 75.5% | 223.6% | -34.4% | · | -22.2% | -18.4% | · | · | -19.9% | -15.8% | -13.4% | · | -12.2% |
Liquidität & Solvenz 2
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 19.1 | 31.1 | · | 9.2 | 3.5 | 3.9 | · | 4.7 | 6.5 | · | · | 10.7 | 15.1 | 17.2 | · | 12.9 | |
| Quick Ratio | 18.8 | 30.6 | · | 9.0 | 3.4 | 3.6 | · | 4.4 | 6.2 | · | · | 10.4 | 14.7 | 16.7 | · | 12.3 |
Bewertung (TTM) 8
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-2.67B | $-2.64B | · | $-2.45B | $-1.66B | $-119M | · | $-119M | $-122M | $-122M | · | $-115M | $-104M | $-97M | · | $-87M | |
| Market Cap | $1.00B | $967M | · | $440M | $4.07B | $1.79B | · | $961M | $1.37B | · | · | $2.87B | $4.17B | $7.20B | · | $3.06B | |
| P/E | -0.0 | -0.1 | · | -0.3 | -1.5 | -1.6 | · | -1.5 | -11.1 | -26.0 | · | -21.2 | -29.6 | -47.8 | · | -34.3 | |
| P/B | -5.0 | -6.4 | · | -0.2 | -2.7 | 27.1 | · | 13.2 | 13.9 | · | · | 16.4 | 20.4 | 31.3 | · | 19.3 | |
| P / Tangible Book | · | · | · | · | · | 27.1 | · | 13.2 | 13.9 | 26.3 | · | 16.4 | 20.4 | 31.3 | · | 19.3 | |
| P / Cash Flow | · | -25.3 | · | · | · | -57.7 | · | · | · | · | · | · | · | -296.8 | · | · | |
| P / FCF | · | -25.2 | · | · | · | -57.3 | · | · | · | · | · | · | · | -295.6 | · | · | |
| Earnings Yield | -2059.4% | -810.0% | · | -292.5% | -65.7% | -63.9% | · | -67.1% | -9.0% | -3.8% | · | -4.7% | -3.4% | -2.1% | · | -2.9% |
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
Gewinn- und Verlustrechnung
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Nettoergebnis | $-696M | $-117M | $-118M | $-92M | $-69M |
| Verwässerte EPS | $-70.50 | $-34.03 | $-1.75 | $-2.33 | $-2.10 |
Bilanz
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Liquiditätsgrad | 18.2 | 5.2 | 9.0 | 18.1 | 21.1 |
| Quick Ratio | 18.1 | 4.9 | 8.8 | 17.6 | 20.4 |
Cashflow
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Freier Cashflow | $-144M | $-100M | $-101M | $-94M | $-73M |
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
📊
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das ➕ neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Institutionelle Eigentümer (13F) 103 Einreicher · $806.9M gesamt · Stand 30. Juni 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 42 (+11 vs. Vorquartal) | 17 (+7 vs. Vorquartal) | 31 (+6 vs. Vorquartal) | 20 (+9 vs. Vorquartal) | +7.3M |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| TCG Crossover Management, LLC | $104.441.366 | 5.673.078 | 12,94% | Aktien |
| FMR LLC | $87.405.893 | 4.747.740 | 10,83% | Aktien |
| FCPM III SERVICES B.V. | $75.800.487 | 4.117.354 | 9,39% | Aktien |
| Venrock Adviser, LLC | $55.998.047 | 3.041.719 | 6,94% | Aktien |
| STATE STREET CORP | $48.166.746 | 2.616.336 | 5,97% | Aktien |
| Frazier Life Sciences Management, L.P. | $46.833.917 | 2.543.939 | 5,80% | Aktien |
| RA CAPITAL MANAGEMENT, L.P. | $44.222.569 | 2.402.095 | 5,48% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $38.372.478 | 2.084.328 | 4,76% | Aktien |
| Caligan Partners LP | $35.440.465 | 1.925.066 | 4,39% | Aktien |
| Paradigm Biocapital Advisors LP | $32.217.500 | 1.750.000 | 3,99% | Aktien |
| GREAT POINT PARTNERS LLC | $31.297.000 | 1.700.000 | 3,88% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $16.677.425 | 905.690 | 2,07% | Aktien |
| NEXTBio Capital Management LP | $16.369.509 | 889.164 | 2,03% | Aktien |
| Nantahala Capital Management, LLC | $15.556.450 | 845.000 | 1,93% | Aktien |
| ADAR1 Capital Management, LLC | $12.530.325 | 680.626 | 1,55% | Aktien |
| Logos Global Management LP | $11.966.500 | 650.000 | 1,48% | Aktien |
| Rosalind Advisors, Inc. | $11.940.726 | 648.600 | 1,48% | Aktien |
| NAN FUNG TRINITY (HK) LTD | $11.902.986 | 646.550 | 1,48% | Aktien |
| BRAIDWELL LP | $10.550.845 | 573.104 | 1,31% | Aktien |
| BOOTHBAY FUND MANAGEMENT, LLC | $10.285.704 | 558.702 | 1,27% | Aktien |
| UBS Group AG | $8.937.300 | 485.459 | 1,11% | Aktien |
| MILLENNIUM MANAGEMENT LLC | $7.880.713 | 428.067 | 0,98% | Aktien |
| SPHERA FUNDS MANAGEMENT LTD. | $7.666.237 | 416.417 | 0,95% | Aktien |
| Woodline Partners LP | $6.990.700 | 379.723 | 0,87% | Aktien |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $6.266.101 | 340.364 | 0,78% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $5.535.961 | 300.704 | 0,69% | Aktien |
| Clearline Capital LP | $5.251.931 | 285.276 | 0,65% | Aktien |
| GOLDMAN SACHS GROUP INC | $4.182.623 | 227.193 | 0,52% | Aktien |
| Eversept Partners, LP | $2.755.627 | 149.681 | 0,34% | Aktien |
| BANK OF AMERICA CORP /DE/ | $2.384.942 | 129.546 | 0,30% | Aktien |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $2.234.937 | 121.398 | 0,28% | Aktien |
| MARSHALL WACE, LLP | $1.760.788 | 95.643 | 0,22% | Aktien |
| AXIOM INVESTORS LLC /DE | $1.695.653 | 92.105 | 0,21% | Aktien |
| XTX Topco Ltd | $1.521.494 | 82.645 | 0,19% | Aktien |
| CITADEL ADVISORS LLC | $1.328.668 | 72.171 | 0,16% | Aktien |
| VANGUARD GROUP INC | $1.227.401 | 93.838 | 0,15% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $1.189.286 | 64.600 | 0,15% | Verkaufsoption |
| CITIGROUP INC | $1.118.868 | 60.775 | 0,14% | Aktien |
| BlackRock, Inc. | $1.082.103 | 58.778 | 0,13% | Aktien |
| RHUMBLINE ADVISERS | $1.059.081 | 57.528 | 0,13% | Aktien |
| ALPS ADVISORS INC | $1.012.513 | 54.998 | 0,13% | Aktien |
| JOHNSON & JOHNSON | $989.206 | 53.732 | 0,12% | Aktien |
| Rafferty Asset Management, LLC | $898.739 | 48.818 | 0,11% | Aktien |
| Walleye Capital LLC | $858.127 | 46.612 | 0,11% | Aktien |
| ALLIANCEBERNSTEIN L.P. | $685.036 | 37.210 | 0,08% | Aktien |
| TWO SIGMA INVESTMENTS, LP | $681.391 | 37.012 | 0,08% | Aktien |
| Engineers Gate Manager LP | $680.268 | 36.951 | 0,08% | Aktien |
| WELLS FARGO & COMPANY/MN | $667.786 | 36.273 | 0,08% | Aktien |
| RENAISSANCE TECHNOLOGIES LLC | $607.733 | 33.011 | 0,08% | Aktien |
| Jefferies Financial Group Inc. | $601.326 | 32.663 | 0,07% | Aktien |
| Bank of New York Mellon Corp | $502.133 | 27.275 | 0,06% | Aktien |
| D. E. Shaw & Co., Inc. | $476.819 | 25.900 | 0,06% | Aktien |
| Sarissa Capital Management LP | $467.596 | 25.399 | 0,06% | Aktien |
| PROFUND ADVISORS LLC | $452.720 | 24.591 | 0,06% | Aktien |
| MetLife Investment Management, LLC | $449.977 | 24.442 | 0,06% | Aktien |
| Squarepoint Ops LLC | $427.683 | 23.231 | 0,05% | Aktien |
| Virtus Investment Advisers, LLC | $419.472 | 22.785 | 0,05% | Aktien |
| TUDOR INVESTMENT CORP ET AL | $361.204 | 19.620 | 0,04% | Aktien |
| Scientech Research LLC | $346.623 | 18.828 | 0,04% | Aktien |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $344.451 | 18.710 | 0,04% | Aktien |
| MORGAN STANLEY | $331.030 | 17.981 | 0,04% | Aktien |
| Vanguard Global Advisers, LLC | $330.404 | 17.947 | 0,04% | Aktien |
| Y-Intercept (Hong Kong) Ltd | $317.352 | 17.238 | 0,04% | Aktien |
| JPMORGAN CHASE & CO | $314.656 | 16.917 | 0,04% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $302.918 | 16.454 | 0,04% | Aktien |
| Invesco Ltd. | $299.568 | 16.272 | 0,04% | Aktien |
| FOX RUN MANAGEMENT, L.L.C. | $281.691 | 15.301 | 0,03% | Aktien |
| NEW YORK STATE COMMON RETIREMENT FUND | $263.263 | 14.300 | 0,03% | Aktien |
| Shay Capital LLC | $252.125 | 13.695 | 0,03% | Aktien |
| Police & Firemen's Retirement System of New Jersey | $221.564 | 12.035 | 0,03% | Aktien |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $198.699 | 10.793 | 0,02% | Aktien |
| EntryPoint Capital, LLC | $198.552 | 10.785 | 0,02% | Aktien |
| BNP PARIBAS FINANCIAL MARKETS | $197.134 | 10.708 | 0,02% | Aktien |
| BARCLAYS PLC | $173.717 | 9.436 | 0,02% | Aktien |
| WELLINGTON MANAGEMENT GROUP LLP | $167.531 | 9.100 | 0,02% | Aktien |
| Nuveen, LLC | $164.309 | 8.925 | 0,02% | Aktien |
| SEI INVESTMENTS CO | $160.500 | 8.714 | 0,02% | Aktien |
| China Universal Asset Management Co., Ltd. | $158.768 | 8.624 | 0,02% | Aktien |
| NORTHERN TRUST CORP | $117.990 | 6.409 | 0,01% | Aktien |
| Legal & General Group Plc | $72.940 | 3.962 | 0,01% | Aktien |
| Ameritas Investment Partners, Inc. | $68.172 | 3.703 | 0,01% | Aktien |
| Russell Investments Group, Ltd. | $59.942 | 3.256 | 0,01% | Aktien |
| GROUP ONE TRADING LLC | $54.549 | 2.963 | 0,01% | Aktien |
| Mirae Asset Global Investments Co., Ltd. | $44.607 | 2.423 | 0,01% | Aktien |
| Global Retirement Partners, LLC | $38.458 | 2.089 | 0,00% | Aktien |
| Pinnacle Wealth Planning Services, Inc. | $36.360 | 1.975 | 0,00% | Aktien |
| Tower Research Capital LLC (TRC) | $32.052 | 1.741 | 0,00% | Aktien |
| ROYAL BANK OF CANADA | $23.000 | 1.259 | 0,00% | Aktien |
| GF FUND MANAGEMENT CO. LTD. | $19.736 | 1.072 | 0,00% | Aktien |
| DEUTSCHE BANK AG\ | $9.886 | 537 | 0,00% | Aktien |
| Sterling Capital Management LLC | $6.536 | 355 | 0,00% | Aktien |
| Jump Financial, LLC | $5.320 | 289 | 0,00% | Aktien |
| PNC Financial Services Group, Inc. | $5.302 | 288 | 0,00% | Aktien |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | $3.314 | 180 | 0,00% | Aktien |
| SIGNATUREFD, LLC | $2.706 | 147 | 0,00% | Aktien |
| MERCER GLOBAL ADVISORS INC /ADV | $1.252 | 68 | 0,00% | Aktien |
| PRICE T ROWE ASSOCIATES INC /MD/ | $770 | 41.815 | 0,00% | Aktien |
| WPG Advisers, LLC | $405 | 22 | 0,00% | Aktien |
| Allworth Financial LP | $185 | 10 | 0,00% | Aktien |
| Parallel Advisors, LLC | $92 | 5 | 0,00% | Aktien |
Unternehmensinsider 18 Insider · 5 Führungskräfte · 14 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Robert Ang | President and CEO | 6. November 2023 F | 680.925 | 0 | 0 | $0 |
| Nathan D. Jorgensen | Chief Financial Officer | 6. November 2023 F | 145.647 | 0 | 0 | $0 |
| Tirtha Chakraborty | Chief Scientific Officer | 6. November 2023 F | 133.952 | 0 | 0 | $0 |
| Eyal C. Attar | Chief Medical Officer | 6. November 2023 F | 51.533 | 0 | 0 | $0 |
| Christopher Slapak | Chief Medical Officer | 1. Februar 2022 A | — | 0 | 0 | $0 |
| David Zaccardelli | Direktor | 7. Juli 2026 A | — | 0 | 0 | $0 |
| Wouter Joustra | Direktor | 11. Juni 2026 A | — | 0 | 0 | $0 |
| Andrew David Levin | Direktor | 11. Juni 2026 A | — | 0 | 0 | $0 |
| Michel Detheux | Direktor | 11. Juni 2026 A | — | 0 | 0 | $0 |
| Fouad Namouni | Direktor | 11. Juni 2026 A | — | 0 | 0 | $0 |
| Alexander Cumbo | Direktor | 11. Juni 2026 A | — | 0 | 0 | $0 |
| Daniella Beckman | Direktor | 11. Juni 2026 A | — | 0 | 0 | $0 |
| Erez Kalir | Direktor | 11. Juni 2026 A | — | 0 | 0 | $0 |
| Joshua Resnick | Direktor | 26. Mai 2023 A | — | 0 | 0 | $0 |
| Sven Ante Lundberg | Direktor | 26. Mai 2023 A | — | 0 | 0 | $0 |
| David Charles Lubner | Direktor | 26. Mai 2023 A | — | 0 | 0 | $0 |
| Matthew R Patterson | Direktor | 26. Mai 2023 A | — | 0 | 0 | $0 |
| Kush Parmar | Direktor | 14. Juni 2022 A | 1.766.634 | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
Aktivisten & 5%+-Eigentümer 4 Beteiligungen
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| RA Capital Management, L.P., Peter Kolchinsky, Rajeev Shah, RA Capital Healthcare Fund, L.P. ×19 Einreichungen | 21. Juli 2026 | 19,90% | Änderung | — | SEC |
| ForGrowth III PA B.V., Forbion Growth Opportunities Fund III Cooperatief U.A., Forbion Growth III Management B.V. | 23. Dezember 2025 | 9,99% | Erste Einreichung | — | SEC |
| Reprogrammed Interchange LLC, Reid Hoffman ×9 Einreichungen | 17. Oktober 2025 | 17,60% | Änderung | — | SEC |
| 5AM Ventures VI, L.P., 5AM Partners VI, LLC, 5AM Opportunities I, L.P., 5AM Opportunities I (GP), LLC, Andrew J. Schwab, Kush Parmar ×3 Einreichungen | 9. Juli 2025 | 3,50% | Änderung | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF-Besitz Gehalten von 19 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| OMFS · Invesco Exchange-Traded Self-Indexe… | 0,23% | 28.259 SH | 8. August 2026 | Täglich |
| IWC · iShares Trust | 0,22% | 138.628 SH | 8. August 2026 | Täglich |
| LABU · Direxion Shares ETF Trust | 0,15% | 54.358 NS | 30. April 2026 | N-PORT |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,09% | 2.946 SH | 8. August 2026 | Täglich |
| IWO · iShares Trust | 0,04% | 257.465 SH | 8. August 2026 | Täglich |
| BIB · ProShares Trust | 0,03% | 1.536 NS | 31. Mai 2026 | N-PORT |
| IWM · iShares Trust | 0,03% | 1.034.461 SH | 8. August 2026 | Täglich |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,03% | 29.989 SH | 8. August 2026 | Täglich |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,02% | 234.796 SH | 8. August 2026 | Täglich |
| IWN · iShares Trust | 0,02% | 116.690 SH | 8. August 2026 | Täglich |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,01% | 15.348 SH | 8. August 2026 | Täglich |
| VXF · VANGUARD INDEX FUNDS | 0,01% | 492.007 SH | 8. August 2026 | Täglich |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,01% | 11.048 SH | 8. August 2026 | Täglich |
| VHT · VANGUARD WORLD FUND | 0,01% | 61.141 SH | 8. August 2026 | Täglich |
| ONEQ · Fidelity Commonwealth Trust | 0,00% | 13.777 NS | 31. Mai 2026 | N-PORT |
| ITOT · iShares Trust | 0,00% | 67.566 SH | 8. August 2026 | Täglich |
| IWV · iShares Trust | 0,00% | 12.959 SH | 8. August 2026 | Täglich |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 1.550.885 SH | 8. August 2026 | Täglich |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 3.390 SH | 8. August 2026 | Täglich |